Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
U.S. FDA
Pharma
Regulatory tracker: GLP-1 probe, Merck, mRNA vaccines and more
Here, we're tracking the regulatory progress of in-market products, including expansions into key geographies and new indications.
Angus Liu
,
Kevin Dunleavy
,
Eric Sagonowsky
,
Fraiser Kansteiner
Dec 1, 2023 11:00am
The FDA handed down 2 new Forms 483 this week
Nov 30, 2023 10:50am
Amid FDA probe, upcoming adcomm could offer key CAR-T guidance
Nov 29, 2023 1:52pm
FDA probes CAR-T therapies' 'serious risk' of secondary cancer
Nov 28, 2023 1:16pm
President Biden unveils supply chain resiliency campaign
Nov 28, 2023 10:51am
US lawyer urges Supreme Court to overturn mifepristone verdict
Nov 27, 2023 3:39pm